Compare Enbridge Inc (ENB) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Heron Therapeutics Inc — how do they compare? Enbridge Inc trades at $51.97 (market cap $112.62B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Enbridge Inc is far larger — about 1832.1× Heron Therapeutics Inc's market cap, and Enbridge Inc pays a 5.34% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ENB | HRTX | |
|---|---|---|
Market Cap | $112.62B | $61.47M |
Sector | Energy | Health |
52-Week High | $58.04 | $1.49 |
52-Week Low | $45.23 | $0.32 |
Enterprise Value | $196.53B | $168.21M |
Dividend Yield | 5.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
